WellCare has contracted with eviti, Inc., an independent third party expert with nearly a decade of experience supporting oncology treatment decisions.
The eviti platform enables providers to access a comprehensive knowledge base of evidence-based cancer treatment guidelines through eviti | Connect. This tool empowers providers with advanced oncology decision support and allows for instant access to thousands of evidence-based treatment regimens. It also provides a streamlined web-based process for pre-authorization of oncology chemotherapy and radiation therapy treatment plans for WellCare members.
eviti | Connect draws on data from the U.S. government, private sector and European guidelines, as well as from reports and journal publications, including JCO, JNCI, Lancet, NEJM and JAMA.
